Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ProNAi Therapeutics Inc | 180,360 | reported | 06 Mar 2018 | tx 5+555,360 |
| Oric Pharmaceuticals, Inc. | 40,000 | reported | 02 Jan 2026 | tx 8+227,508 |
| RayzeBio, Inc. | 0 | reported | 26 Feb 2024 | tx 2−114,579 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 23 Jun 2025 | PURCHASE | Oric Pharmaceuticals, Inc. | 1,403 | 9.43 USD | |
| 20 Jun 2025 | PURCHASE | Oric Pharmaceuticals, Inc. | 26,597 | 9.39 USD | first after silence |
| 02 Jan 2025 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 35,000 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 25,600 | 0.00 USD | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 73,731 | — | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 40,848 | — | deriv |
| 14 Jun 2023 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 20,500 | 0.00 USD | deriv |
| 17 Jun 2022 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 45,158 | 0.00 USD | deriv |
| 09 Nov 2021 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 33,250 | 0.00 USD | deriv |
| 06 Mar 2018 | GRANT_AWARD | ProNAi Therapeutics Inc | 180,360 | 0.00 USD | deriv |
| 08 Mar 2017 | PURCHASE | ProNAi Therapeutics Inc | 30,000 | 1.43 USD | |
| 06 Mar 2017 | GRANT_AWARD | ProNAi Therapeutics Inc | 70,000 | 0.00 USD | deriv |
| 30 Sept 2016 | GRANT_AWARD | ProNAi Therapeutics Inc | 200,000 | 0.00 USD | deriv |
| 08 Mar 2016 | GRANT_AWARD | ProNAi Therapeutics Inc | 75,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 20 Jun 2025.